Hawaii SB2855 mandates coverage for opioid antagonists and devices in health insurance policies.

Hawaii SB2855 amends the Hawaii Revised Statutes to require coverage for opioid antagonists and devices in health insurance policies. Starting January 1, 2027, individual or group policies, health maintenance organizations, and hospital or medical service plans must cover at least one generic opioid antagonist and device. These must be placed on the lowest cost-sharing tier, exempt from annual or lifetime dollar limitations, and not require prior authorization unless for non-generic forms.

Hawaii SB2855 mandates coverage for opioid antagonists and devices in health insurance policies.

Hawaii SB2855 amends the Hawaii Revised Statutes to require coverage for opioid antagonists and devices in health insurance policies. Starting January 1, 2027, individual or group policies, health maintenance organizations, and hospital or medical service plans must cover at least one generic opioid antagonist and device. These must be placed on the lowest cost-sharing tier, exempt from annual or lifetime dollar limitations, and not require prior authorization unless for non-generic forms.